The study of genetic polymorphisms related to serotonin in Alzheimer's disease: A new perspective in a heterogenic disorder

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 4, 1999, Pages 463-467

  Oliveira, J R M ^a,b   Zatz, M ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allelic association; Alzheimer's disease; Serotonin polymorphisms

Indexed keywords

SCAVENGER; SEROTONIN;

ALZHEIMER DISEASE; GENETIC POLYMORPHISM; GENETICS; HUMAN; PHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; FREE RADICAL SCAVENGERS; HUMANS; POLYMORPHISM, GENETIC; SEROTONIN;

EID: 0033111860     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000400014     Document Type: Article

References (40)

1. Eastwood R, Amaducci L, Brayne C, Broe T, Burns A, Copeland J, Dickens B, Goate A, Hachinski V, Henderson S, Jolles J, Morris J, Ritchie K, Roses A, Rossor M, Schellenberg G, Skoog I, Storandt M, Tallis R, Whitehouse P, Clark S, Evans I, Horton R & Sharp D (1996). The challenge of the dementias. Lancet, 374: 1303-1307.
2. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Ginffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M & Hardy J (1991). Segregation of a missense mutation in amyloid precusor protein gene with familial Alzheimer's disease. Nature, 349: 704-706.
3. Sherrington R, Rogaev El, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbis S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookses A, Sansean P, Polinsky RJ, Wasco W, da Silva HAR, Haines JL, Pericak-Vance MA, Tanzy RE, Roses AD, Fraser PE, Rommens JM & St. George-Hyslop PH (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375: 754-760.
4. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weber JL, Bird TD & Schellenberg GD (1995). A familial Alzheimer's disease locus on chromosome 1. Science, 269: 970-973.
5. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettigel WH, Yu C, Jondro PD, Schimidt SD, Wang K, Crowley AC, Fu YH, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD & Tanzi RE (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 269: 973-977.
6. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PO, Scott WK, Terwedon HÁ, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD & Haines JL (1997). Complete genomic screen in late-onset familial Alzheimer disease: Evidence for a new locus on chromosome 12. Journal of the American Medical Association, 278: 1237-1241.
7. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance MA, Enghild J, Salvesen GS & Roses AD (1993). Apolipoprotein E: High avidity binding to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 190: 1977-1981.
8. Oliveira JRM, Shimokomaki CM, Brito-Marques PR, Okuma M, Passos-Bueno MR, Zatz M & Lima-Filho JL (1997). The use of apolipoprotein E genotype for pre-clinical detection of Risk's group for Alzheimer's disease. American Journal of Medical Genetics (Neuropsychiatric Genetics), 74: 216-217.
9. Artiga MJ, Bullido MJ, Frank A, Sastre I, Recuero M, Garcia MA, Lendon CL, Han SW, Morris JC, Vásquez J, Goate A & Valdivieso F (1998). Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Human Molecular Genetics, 7: 1887-1892.
10. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tu J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P & Chartier-Harlin MC (1998). Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE expression and risk of developing Alzheimer's disease. Human Molecular Genetics, 7: 1511-1516.
11. Leuween FWV, Kleijn DPV, van den Hurk HH, Neubauer A, Sonnemans MAF, Sluijs JÁ, Köycü S, Ramdjielal RDJ, Salehi A, Martens GJM, Grosveld FG, Burbach PH & Hol EM (1998). Frameshift mutants of ß amyloid precussor protein and ubiquitin-B in Alzheimer's and Down patients. Science, 279: 242-247.
12. Meltzer H, Arora R, Baber R & Tricou B (1981). Serotonin uptake in blood platelets of psychiatric patients. Archives of General Psychiatry, 38: 1322-1329.
13. Risch SC & Nemeroff CB (1981). Neuro-chemical alterations of serotoninergic neuronal systems in depression. Journal of Clinical Psychiatry, 38: 1322-1329.
14. Sthal S, Woo D, Mefford I, Berger P & Ciaranello R (1983). Hyperserotonemia and platelet serotonin uptake in schizophrenia and affective disorders. American Journal of Psychiatry, 140: 26-31.
15. Joyce JN, Shame A, Lexow N, Winokur A, Casanova MF & Kleinman JE (1993). Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology, 8: 315-336.
16. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH & Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274: 1527-1531.
17. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P & Lesch KP (1996). A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry, 1: 453-460.
18. Lesch KP, Wolozin BL, Estler HC, Murphy DL & Riederer P (1993). Isolation of a cDNA encoding the human brain serotonin transporter. Journal of Neural Transmission, 91: 67-73.
19. Lesch KP, Balling U, Gross J, Strauss K, Murphy DL & Riederer P (1994). Organization of the human serotonin transporter gene. Journal of Neural Transmission (Genetic Section), 95: 157-162.
20. Ramamoorthy S, Bauman A, Moore K, Han H, Yang-Feng L, Chang A, Ganapathy V & Blakely R (1993). Regulation of the human serotonin transporter: Antidepressant and cocaine sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proceedings of the National Academy of Sciences, USA, 90: 2542-2546.
21. Gelernter J, Pakstis AJ & Kidd KK (1995). Linkage mapping of the serotonin transporter protein gene SCL 6 A4 on chromosome 17. Human Genetics, 96: 677-680.
22. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D & Lesch KP (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66: 2621-2626.
23. Kunugi H, Tatsumi M, Sakai T, Hattori M & Nanko S (1996). Serotonin transporter gene polymorphism and affective disorder. Lancet, 347: 1340 (Abstract).
24. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y & Belmaker RH (1997). No association between the serotonin transporter gene regulatory region polymorphism and the three dimensional personality questionnaire (TPQ) temperamental of harm avoidance. Molecular Psychiatry, 2: 224-226.
25. Klauck SM, Poustka F, Benner A, Lesch KP & Poustka A (1997). Serotonin transporter (5-HTT) gene variants associated with autism? Human Molecular Genetics, 6: 2233-2238.
26. Deckert J, Catalano M, Heils A, Di Bella D, Friess F, Politi E, Franke P, Nothen MM, Maier W, Bellodi L & Lesch KP (1997). Functional promoter polymorphism of the human serotonin transporter: Lack of association with panic disorder. Psychiatric Genetics, 7: 45-47.
27. Billet EA, Richter MA, King N, Heils A, Lesch KP & Kennedy JL (1997). Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Molecular Psychiatry, 2: 403-406.
28. Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D, Macher JP, Sander T & Crocq MA (1998). Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. American Journal of Medical Genetics (Neuropsychiatric Genetics), 81: 1-3.
29. Esterling LE, Yoshikawa T, Turner G, Badner JÁ, Bengel D, Gershon ES, Berrettini WH & Detera-Wadleigh SD (1998). Serotonin transporter (5-HTT) gene and bipolar affective disorder. American Journal of Medical Genetics (Neuropsychiatric Genetics), 81: 37-40.
30. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, Easton DF & Rubinsztein DC (1998). Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. American Journal of Medical Genetics (Neuropsychiatric Genetics), 81: 58-63.
31. Oliveira JRM, Otto PA, Vallada HP, Lauriano V, Elkis H, Lafer B, Vasques L, Gentil V, Passos-Bueno MR & Zatz M (1998). Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia. American Journal of Medical Genetics (Neuropsychiatric Genetics), 81: 225-227.
32. Li T, Holmes C, Sham PC, Vallada HP, Birkett J, Kirov G, Lesch KP, Powell J, Lovestone S & Collier D (1997). Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. NeuroReport, 8: 683-686.
33. Oliveira JRM, Gallindo RM, Maia LGS, Brito-Marques PR, Otto PA, Passos-Bueno MR, Morais Jr MA & Zatz M (1998). The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease. Molecular Psychiatry, 3: 438-441.
34. Oliveira JRM, Shimokomaki CM, Brito-Marques PR, Gallindo RM, Okuma M, Maia LGS, Otto PA, Passos-Bueno MR & Zatz M (1999). The association of the short variant of the 5-HTTLPR polymorphism and the apoE ε4 allele does not increase the risk for late onset Alzheimer's disease. Molecular Psychiatry, 4: 19-20.
35. Williams J, McGuffin P, Nöthen M, Owen MJ & the EMASS Consortium (1997). Meta-analysis of association between the 5-HT receptor T102C polymorphism and schizophrenia. Lancet, 349: 1221.
36. a-receptor gene. Lancet, 347: 1294-1296.
37. 2A receptor genes. Lancet, 346: 281-282.
38. Holmes C, Arranz MJ, Powell AF, Collier DA & Lovestone S (1998). 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Human Molecular Genetics, 7: 1507-1509.
39. 2A receptor and response to clozapine. Lancet, 346: 909.
40. Feinberg T & Goodman B (1984). Affective illness, dementia and pseudodementia. Journal of Clinical Psychiatry, 3: 99-103.